Elanco Animal Health Incorporated ELAN stock is tumbling as the company released updates to the expected FDA approval timelines for Zenrelia and Credelio Quattro.

Elanco Provides Innovation Update

06:27am, Thursday, 27'th Jun 2024
Major technical sections complete for Zenrelia, with FDA final approval on track for late in third quarter of 2024; updates on differentiation and safety Final FDA approval for Credelio Quattro now e
Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GREENFIELD, Ind. , June 6, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 45th Annual Global Healthcare Conference, June 11-12, 2024.
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Ruminant Methane Reduction Market Size, Share & Trends Analysis Report By Product (Feed Additives/ Supplements (Plant-based, Chemical-based, Microbial-ba
Elanco Animal Health (ELAN) develops and manufactures products for pets and farm animals. CEO Jeffrey Simmons joins Nicole Petallides to give an overview of the company and discuss Bovaer, ELAN's 1st
The U.S. Food and Drug Administration has approved Elanco Animal Health's methane-reducing feed ingredient for lactating dairy cows, the company said on Tuesday.
Food and Drug Administration confirms Bovaer meets safety and efficacy requirements Elanco expects product launch and added carbon credit value to producers beginning in the third quarter Elanco anno
GREENFIELD, Ind. , May 21, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024.

Elanco Animal Health (ELAN) CEO on Earnings

06:46pm, Wednesday, 08'th May 2024
Elanco Animal Health (ELAN) CEO Jeffrey Simmons joins Oliver Renick to discuss ELAN's 1Q earnings. He talks about how ELAN's shares hit a 52-week high.
Although the revenue and EPS for Elanco Animal Health (ELAN) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with
First Quarter 2024 Financial Results Revenue of $1,205 million Reported Net income of $32 million, Adjusted Net income of $167 million Adjusted EBITDA of $294 million, or 24.4% of Revenue Reported EPS
Beyond analysts' top -and-bottom-line estimates for Elanco Animal Health (ELAN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed fo
GREENFIELD, Ind. , April 17, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024.
New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee Reaches Cooperation Agreement with Ancora GREENFIELD, Ind. , April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorpo
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE